- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/0783 - Cellules TCellules NKProgéniteurs de cellules T ou NK
Détention brevets de la classe C12N 5/0783
Brevets de cette classe: 11662
Historique des publications depuis 10 ans
|
315
|
474
|
639
|
846
|
927
|
1050
|
1205
|
1107
|
1211
|
949
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1154 |
686 |
| Iovance Biotherapeutics, Inc. | 343 |
256 |
| The Regents of the University of California | 20137 |
233 |
| The Trustees of the University of Pennsylvania | 4354 |
210 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2882 |
149 |
| Board of Regents, The University of Texas System | 5884 |
147 |
| Cellectis | 406 |
130 |
| Memorial Sloan-Kettering Cancer Center | 1960 |
117 |
| Juno Therapeutics, Inc. | 423 |
116 |
| Baylor College of Medicine | 963 |
105 |
| Novartis AG | 10709 |
99 |
| The Board of Trustees of the Leland Stanford Junior University | 6487 |
99 |
| Immunitybio, Inc. | 403 |
88 |
| City of Hope | 1001 |
87 |
| Autolus Limited | 257 |
84 |
| Kite Pharma, Inc. | 408 |
82 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 971 |
79 |
| Regents of the University of Minnesota | 2711 |
75 |
| FATE Therapeutics, Inc. | 209 |
72 |
| Kyoto University | 2831 |
66 |
| Autres propriétaires | 8682 |